499 related articles for article (PubMed ID: 23075177)
1. Linezolid for treatment of chronic extensively drug-resistant tuberculosis.
Lee M; Lee J; Carroll MW; Choi H; Min S; Song T; Via LE; Goldfeder LC; Kang E; Jin B; Park H; Kwak H; Kim H; Jeon HS; Jeong I; Joh JS; Chen RY; Olivier KN; Shaw PA; Follmann D; Song SD; Lee JK; Lee D; Kim CT; Dartois V; Park SK; Cho SN; Barry CE
N Engl J Med; 2012 Oct; 367(16):1508-18. PubMed ID: 23075177
[TBL] [Abstract][Full Text] [Related]
2. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
[TBL] [Abstract][Full Text] [Related]
3. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Koh WJ; Kwon OJ; Gwak H; Chung JW; Cho SN; Kim WS; Shim TS
J Antimicrob Chemother; 2009 Aug; 64(2):388-91. PubMed ID: 19468028
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
[TBL] [Abstract][Full Text] [Related]
5. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
Xu HB; Jiang RH; Li L; Xiao HP
Int J Tuberc Lung Dis; 2012; 16(3):358-63. PubMed ID: 22640450
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of linezolid in the treatment of extensively drug-resistant tuberculosis.
Tangg SJ; Zhang Q; Zheng LH; Sun H; Gu J; Hao XH; Liu YD; Yao L; Xiao HP
Jpn J Infect Dis; 2011; 64(6):509-12. PubMed ID: 22116331
[TBL] [Abstract][Full Text] [Related]
7. Linezolid in the treatment of extensively drug-resistant tuberculosis.
Zhang L; Pang Y; Yu X; Wang Y; Gao M; Huang H; Zhao Y
Infection; 2014 Aug; 42(4):705-11. PubMed ID: 24902521
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of MDR/XDR-TB patients treated with linezolid: experience in Thailand.
Roongruangpitayakul C; Chuchottaworn C
J Med Assoc Thai; 2013 Oct; 96(10):1273-82. PubMed ID: 24350407
[TBL] [Abstract][Full Text] [Related]
9. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
Nam HS; Koh WJ; Kwon OJ; Cho SN; Shim TS
Int J Antimicrob Agents; 2009 Jan; 33(1):92-3. PubMed ID: 18789655
[No Abstract] [Full Text] [Related]
10. Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis.
Dauby N; Muylle I; Mouchet F; Sergysels R; Payen MC
Pediatr Infect Dis J; 2011 Sep; 30(9):812-3. PubMed ID: 21378593
[TBL] [Abstract][Full Text] [Related]
11. Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis.
Condos R; Hadgiangelis N; Leibert E; Jacquette G; Harkin T; Rom WN
Chest; 2008 Jul; 134(1):187-92. PubMed ID: 18628223
[TBL] [Abstract][Full Text] [Related]
12. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
Anger HA; Dworkin F; Sharma S; Munsiff SS; Nilsen DM; Ahuja SD
J Antimicrob Chemother; 2010 Apr; 65(4):775-83. PubMed ID: 20150181
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.
Alffenaar JW; van Altena R; Harmelink IM; Filguera P; Molenaar E; Wessels AM; van Soolingen D; Kosterink JG; Uges DR; van der Werf TS
Clin Pharmacokinet; 2010 Aug; 49(8):559-65. PubMed ID: 20608757
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China.
Tang S; Yao L; Hao X; Zhang X; Liu G; Liu X; Wu M; Zen L; Sun H; Liu Y; Gu J; Lin F; Wang X; Zhang Z
Eur Respir J; 2015 Jan; 45(1):161-70. PubMed ID: 25234807
[TBL] [Abstract][Full Text] [Related]
15. Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.
Abbate E; Vescovo M; Natiello M; Cufré M; García A; Gonzalez Montaner P; Ambroggi M; Ritacco V; van Soolingen D
J Antimicrob Chemother; 2012 Feb; 67(2):473-7. PubMed ID: 22134348
[TBL] [Abstract][Full Text] [Related]
16. Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis.
Cox H; Ford N
Int J Tuberc Lung Dis; 2012 Apr; 16(4):447-54. PubMed ID: 22325685
[TBL] [Abstract][Full Text] [Related]
17. Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India.
Singla R; Caminero JA; Jaiswal A; Singla N; Gupta S; Bali RK; Behera D
Eur Respir J; 2012 Apr; 39(4):956-62. PubMed ID: 21965225
[TBL] [Abstract][Full Text] [Related]
18. On linezolid efficacy and tolerability.
De Lorenzo S; Centis R; D'Ambrosio L; Sotgiu G; Migliori GB
Eur Respir J; 2012 Mar; 39(3):770-2. PubMed ID: 22379150
[No Abstract] [Full Text] [Related]
19. Can intermittent dosing optimize prolonged linezolid treatment of difficult multidrug-resistant tuberculosis?
Chang KC; Yew WW; Cheung SW; Leung CC; Tam CM; Chau CH; Wen PK; Chan RC
Antimicrob Agents Chemother; 2013 Jul; 57(7):3445-9. PubMed ID: 23650165
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.
Conradie F; Diacon AH; Ngubane N; Howell P; Everitt D; Crook AM; Mendel CM; Egizi E; Moreira J; Timm J; McHugh TD; Wills GH; Bateson A; Hunt R; Van Niekerk C; Li M; Olugbosi M; Spigelman M;
N Engl J Med; 2020 Mar; 382(10):893-902. PubMed ID: 32130813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
